Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating income | -$2.09M | -$31.3M | -$38.0M | -$34.3M | -$30.8M |
| Net income | $26.0M | -$12.6M | -$36.4M | -$33.9M | -$29.5M |
| EPS (diluted) | $1.12 | -$0.35 | -$0.47 | -$0.37 | -$0.27 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$2.17M | -$9.91M | -$31.3M | -$31.5M | -$25.4M |
| Capital expenditures | $879K | $492K | $1.05M | $143K | $196K |
| Free cash flow | -$3.05M | -$10.4M | -$32.4M | -$31.6M | -$25.6M |
| Dividends paid | $4.36M | $0.00 | — | — | — |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $11.4M | $23.9M | $25.5M | $9.41M | $29.7M |
| Total assets | $70.6M | $105M | $108M | $95.4M | $116M |
| Total liabilities | $11.6M | $3.85M | $4.67M | $3.20M | $3.34M |
| Shareholders' equity | $37.8M | $114M | $104M | $92.2M | $113M |
| Retained earnings | $25.7M | -$6.22M | -$42.7M | -$76.5M | -$106M |
| Shares (wtd avg diluted) | 23.2M | 35.6M | 78.3M | 90.9M | 109M |
Every figure is extracted from Dakota Gold Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.